Publikationen 2007


Rebholz B, Haase I, Eckelt B, Paxian S, Flaig MJ, Ghoreschi K, Nedospasov SA, Mailhammer R, Debey-Pascher S, Schultze JL, Weindl G, Förster I, Huss R, Stratis A, Ruzicka T, Röcken M, Pfeffer K, Schmid RM, Rupec RA. Crosstalk between keratinocytes and adaptive immune cells in an IkappaBalpha protein-mediated inflammatory disease of the skin. Immunity 27: 296-307; 2007. PubMed

Lange C, Durr M, Doster H, Melms A, Bischof F. Dendritic cell-regulatory T-cell interactions control self-directed immunity. Immunol Cell Biol. 2007 Jun 26 [Epub ahead of print]. PubMed

Feger U, Luther C, Schreiner B, Poeschel S, Melms A, Tolosa E, Wiendl H. The frequency of CD4+CD25bright T regulatory cells is increased in the CSF but not in the blood of MS patients. Clin Immunol 2007;147:412-418. PubMed

Rosenkranz D, Weyer S, Tolosa E, Gänslen A, Berg D, Leyhe T, Gasser T, Stoltze L. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol  2007 (in press)

Burster T, Beck A, Poeschel S, Oren A, Baechle D, Reich M, Rötzschke O, Falk K, Youssef S, Kalbacher H, Overkleeft H, Tolosa E, Driessen C. Interferon-gamma regulates cathepsin G activity and controls the proteolytic processing of myelin basic protein in vitro. Immunology 2007;121:82-93. PubMed

Viken MK, Dahlen Sollid H, Joner G, Dahl-Jørgensen K, Rønningen KS, Undlien DE, Flato B, Selvaag AM, Forre O, Kvien TK, Thorsby E, Melms A, Tolosa E, Benedicte A. Lie. The cathepsin L2 (CTSL2) gene, important for antigen presentation in thymus, shows association with type 1 diabetes and myasthenia gravis. Human Immunol 2007 (in press)

Adamopoulou EC, Diekmann J, Tolosa E, Kuntz G, Einsele H, Rammensee HG, Topp M. Human CD4+ T cells displaying viral epitopes elicit a full virus-specific CD8+ T cell response. J Immunol 2007;178:5465-5472. PubMed

Feger U, Tolosa E, Huang YH, Waschbisch A, Biedermann T, Melms A, Wiendl H. HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation. Blood. 2007; 110:568-577. PubMed

Gouttefangeas C, Stenzl A, Stevanovic; S, Rammensee HG. Immunotherapy of renal cell carcinoma. Cancer Immunol Immunother. 2007;56:117-28. PubMed

Kraus D, Kalbacher H, Buschmann J, Berger-Bächi B, Götz F, Peschel A. Muropeptide amidation in Staphylococcus aureus: amidation of peptidoglycan d-glutamate does not affect the proinflammatory activity of S. aureus. Infect Immun. 2007;75:2084-2087. PubMed

Essin K, Salanova B, Kettritz R, Sausbier M, Luft FC, Kraus D, Bohn E, Autenrieth IB, Peschel A, Ruth P, Gollasch M. Large-conductance calcium-activated potassium channel activity is absent in human and mouse neutrophils and is not required for innate immunity. Am J Physiol Cell Physiol. 2007;293:C45-54. PubMed

Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M. Identification of novel cytolytic peptides as key virulence determinants of community-associated MRSA. Nat Med. In press

Fedke I, Mader D, Moll H, Nicholson G, Biswas R, Henseler K, Hornig G, Götz F, Zähringer U, Peschel A. A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity. Mol Microbiol. 2007;65:1078-1091. PubMed

Weindl G, Naglik JR, Kaesler S, Biedermann T, Hube B, Korting HC, Schaller M. Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest. 2007;117:3664-3672; 2007. PubMed

Kneilling M, Hültner L, Pichler BJ, Mailhammer R, Morawietz L, Solomon S, Eichner M, Sabatino J, Biedermann T, Krenn V, Weber WA, Illges H, Haubner R, Röcken M. Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice. Arthritis Rheum. 56:1806-181; 2007. PubMed